RxDoctor Payments Data

Jane Myung, MD

Ophthalmology · Lacey, WANPI 1063616472

Payments from drug & device makers

$373in general payments, 2019–2025

Across 12 payments — averaging $31.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$200
  • Genentech USA, Inc.$58
  • Astellas Pharma US Inc$56
  • AbbVie$52
  • Alimera Sciences, Inc.$7

What the payments were for

  • Food & beverage$373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alcon3$200
Genentech USA, Inc.3$58
Astellas Pharma US Inc3$56
AbbVie(2 entities)2$52
Alimera Sciences, Inc.1$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$373 in reported general payments places this provider in the 35th percentile of 428 ophthalmology providers in Washington.

See all ophthalmology providers in Washington

Medicare billing

Part B allowed, 2024
$3,237,752
Medicare patients
816
Services billed
50,997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate103$5,063
Bromfenac Sodium16$2,067
Mycophenolate Mofetil13$1,496
Difluprednate11$920
Ofloxacin65$786
Timolol Maleate20$454
Latanoprost14$163
Brimonidine Tartrate16$111
Prednisone12$35

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Lacey

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →